We regularly have new studies that we are recruiting for. If you don’t see something that you qualify for right now, please call Caitlin at 952-993-9605 or complete the questionnaire at this link to be contacted about future studies.
CGM FOR THE EARLY DETECTION AND MANAGEMENT OF HYPERGLYCEMIA IN PREGNANCY (IMAGINE)
Study Sponsor: Leona M. and Harry B. Helmsley Charitable Trust, Dexcom Inc., and Abbott Diabetes
Care, Inc.
Location: International Diabetes Center, Health Center for Women or the Women’s Center
Purpose of study: To better understand how managing glucose levels beginning early in pregnancy may affect the health of the mother and baby. A continuous glucose monitor (CGM) will be used. A continuous glucose monitor or CGM is a device used to track your glucose levels all of the time.
What Happens in the study?
You will be asked to:
– Attend routine prenatal appointments
– Attend 1-2 clinic visits for the study
– Be willing to wear a CGM sensor throughout the entire pregnancy
– Be willing to receive glucose management with CGM or with usual care if you have high blood sugars
Participants will be provided:
– CGM supplies
– Stipend for participation
Inclusion Criteria:
You may be eligible if:
– You are at least 18 years of age
– You are pregnant with one baby
– You will be pregnant for about 14 weeks or less at the first visit with study team
– You speak English or Spanish
– You are receiving your pregnancy care at the Health Center for Women or the Women’s Center
– You do not have diabetes or a history of gestational diabetes
Study Contact:
Shannon Krizka
(952) 993-2092
imaginestudy@healthpartners.com
CONtiNuous glucosE monitoring (CGM) in people wiTh type 2 diabetes not on insulin: The CONNECT Study
Study sponsor: Dexcom
Location: International Diabetes Center
Purpose of study: This research study is being done to better understand how using continuous glucose monitoring (CGM), along with your usual diabetes medications, works to improve blood sugars compared to your usual diabetes management. Each qualifying participant will have the opportunity to use a CGM.
The CGM is a small device worn on the upper arm that allows you to see what your blood sugar level is at any time of the day. The system has a sensor that measures blood sugar level continuously and the results can be seen on your smartphone.
Participants will receive the following, at no cost:
– Study-related medical care and lab tests
– Continuous glucose monitoring supplies
– Payment for completed visits
Inclusion Criteria
You may qualify if you:
– Are age 18 or older
– Have type 2 diabetes
– Do NOT take insulin
– Have an A1C of 7.5% or higher
– Have never used a CGM, or have not used one recently
– Meet other study specific requirements
Study Contact:
Caitlin Moening
(952) 993-9605
IDCResearch@ParkNicollet.com
Observation and Identification of Glycemic Metrics and Patterns in People with and without Prediabetes (PREMAP)
Study Sponsor: Abbott Diabetes Care
Location: International Diabetes Center
Purpose of study: Help us better understand glucose patterns for those with or without prediabetes. The purpose of this research study is to observe and identify patterns in how a person’s glucose changes using the FreeStyle Libre 3 Continuous Glucose Monitoring (CGM) System. This study will include people with and without prediabetes. The study includes 2-3 appointments over a period of about 15-20 days. Information collected in this study could lead to new and potentially more effective methods to diagnose prediabetes and may help to better understand ways in which continuous glucose monitoring can be used for persons with prediabetes or glucose tolerance issues.
Participants will receive:
– The study system to use during participation
– Compensation for completed visits
– Study related lab tests at no cost
Inclusion Criteria:
You may qualify if you:
– Have been diagnosed with prediabetes. The study is also enrolling those who do not have prediabetes.
– Are not taking medications for diabetes or weight loss
– Are willing to wear a continuous glucose monitor
– Are willing to complete an oral glucose tolerance test
– Meet other study specific requirements
Exclusion Criteria:
– Individuals with a diagnosis of diabetes are not eligible.
Study Contact:
Caitlin Moening
(952) 993-9605
IDCResearch@parknicollet.com
Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination with Insulin Aspart, in Adults with Type 1 Diabetes
Study Sponsor: Novo Nordisk
Location: International Diabetes Center
Phase of Study: Phase III
Purpose of study:
We are conducting a research study for people with type 1 diabetes comparing a once weekly basal insulin to once daily basal insulin.
We will provide participants one of two different long-acting insulins at no cost, to see how much it helps with managing blood sugars. We are also providing mealtime insulin at no cost. We are doing this study to look at how much a new investigational once weekly insulin improves blood sugar in people with type 1 diabetes. This will be compared to a currently available once daily basal insulin.
Participants will receive a stipend for completed visits.
Dexcom G7 continuous glucose monitoring (CGM) supplies will be provided at no cost.
Inclusion Criteria:
We are inviting all adults who:
– Have type 1 diabetes
– Take multiple injections of insulin a day
– Have an A1C 7-10%.
– Meet other study specific requirements
Study Contact:
Caitlin Moening
(952) 993-9605
IDCResearch@parknicollet.com
